FDAFDA · Food and drugs·Recall number D-886-2013
Rifadin (rifampin) capsules, USP, 150 mg, 100-count capsules per bottle, Manufactured by: Fabrique par Sanofi-Aventis Canada Inc., Laval, Quebec, Canada H7L4A8, DIN # 02091887
Published August 21, 2013 · Recall initiated: February 26, 2013
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Subpotent Drug: During review of retain samples, the manufacturer observed low fill in some capsules, which was related to an issue detected with the encapsulating equipment.
What to do
Voluntary: Firm initiated · Letter
Recall details
- Manufacturer
- Sanofi-Synthelabo
- Distributor
- Canada
- Lot
- Lot # 3099036, Exp 03/2014
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- Canada
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.